Skip to main content
Top
Published in: Journal of Clinical Monitoring and Computing 2/2022

21-03-2021 | Rocuronium | Brief Communication

Extravascular leakage of induction doses of rocuronium: four cases in which both depth of neuromuscular block and plasma concentration of rocuronium were assessed

Authors: Shunichi Takagi, Miho Kijima, Hajime Iwasaki, Akira Doshu-Kajiura, Osamu Kitajima, Takahiro Suzuki

Published in: Journal of Clinical Monitoring and Computing | Issue 2/2022

Login to get access

Abstract

The duration of action of extravasated rocuronium varies depending on the patient’s comorbidities. In patients who receive high doses of non-depolarizing neuromuscular blocking agents subcutaneously, anesthesiologists should be aware of unexpected prolongation of the progress and recovery of neuromuscular block. In such cases, the depth and recovery of neuromuscular block should be objectively monitored to avoid residual neuromuscular block and recurarization.
Literature
1.
go back to reference Iwasaki H, Namiki A, Omote T, Omote K. Neuromuscular effects of subcutaneous administration of pancuronium. Anesthesiology. 1992;76:1049–51.CrossRef Iwasaki H, Namiki A, Omote T, Omote K. Neuromuscular effects of subcutaneous administration of pancuronium. Anesthesiology. 1992;76:1049–51.CrossRef
2.
go back to reference Cammu G, De Kam PJ, Demeyer I, Decoopman M, Peeters PAM, Smeets JMW, Foubert L. Safety and tolerability of single intravenous doses of sugammadex administered simultaneously with rocuronium or vecuronium in healthy volunteers. Br J Anaesth. 2008;100:373–9.CrossRef Cammu G, De Kam PJ, Demeyer I, Decoopman M, Peeters PAM, Smeets JMW, Foubert L. Safety and tolerability of single intravenous doses of sugammadex administered simultaneously with rocuronium or vecuronium in healthy volunteers. Br J Anaesth. 2008;100:373–9.CrossRef
3.
go back to reference Magorian T, Wood P, Caldwell J, et al. The pharmacokinetics and neuromuscular effects of rocuronium bromide in patients with liver disease. Anesth Analg. 1995;80:754–9.PubMed Magorian T, Wood P, Caldwell J, et al. The pharmacokinetics and neuromuscular effects of rocuronium bromide in patients with liver disease. Anesth Analg. 1995;80:754–9.PubMed
4.
go back to reference Suzuki T, Masaki G, Ogawa S. Neostigmine-induced reversal of vecuronium in normal weight, overweight and obese female patients. Br J Anaesth. 2006;97:160–3.CrossRef Suzuki T, Masaki G, Ogawa S. Neostigmine-induced reversal of vecuronium in normal weight, overweight and obese female patients. Br J Anaesth. 2006;97:160–3.CrossRef
5.
go back to reference Kim KS, Jeon JW, Koh MS, Shim JH, Cho SY, Suh JK. The duration of immobilization causes the changing pharmacodynamics of mivacurium and rocuronium in rabbits. Anesth Analg. 2003;96:438–42.CrossRef Kim KS, Jeon JW, Koh MS, Shim JH, Cho SY, Suh JK. The duration of immobilization causes the changing pharmacodynamics of mivacurium and rocuronium in rabbits. Anesth Analg. 2003;96:438–42.CrossRef
6.
go back to reference Driessen JJ, Robertson EN, Booij LH, Vree TB. Accelerated recovery and disposition from rocuronium in an end-stage renal failure patient on chronic anticonvulsant therapy with sodium valproate and primidone. Br J Anaesth. 1998;80:386–8.CrossRef Driessen JJ, Robertson EN, Booij LH, Vree TB. Accelerated recovery and disposition from rocuronium in an end-stage renal failure patient on chronic anticonvulsant therapy with sodium valproate and primidone. Br J Anaesth. 1998;80:386–8.CrossRef
7.
go back to reference Moriyama T, Matsunaga A, Nagata O, et al. Effective method of continuous rocuronium administration based on effect-site concentrations using a pharmacokinetic/pharmacodynamic model during propofol–remifentanil anesthesia. J Anesth. 2015;29:593–9.CrossRef Moriyama T, Matsunaga A, Nagata O, et al. Effective method of continuous rocuronium administration based on effect-site concentrations using a pharmacokinetic/pharmacodynamic model during propofol–remifentanil anesthesia. J Anesth. 2015;29:593–9.CrossRef
8.
go back to reference Navare SR, Garcia Medina O, Prielipp RC, Weinkauf JL. Sugammadex reversal of a large subcutaneous depot of rocuronium in a dialysis patient: a case report. A A Pract. 2019;12:375–7.CrossRef Navare SR, Garcia Medina O, Prielipp RC, Weinkauf JL. Sugammadex reversal of a large subcutaneous depot of rocuronium in a dialysis patient: a case report. A A Pract. 2019;12:375–7.CrossRef
Metadata
Title
Extravascular leakage of induction doses of rocuronium: four cases in which both depth of neuromuscular block and plasma concentration of rocuronium were assessed
Authors
Shunichi Takagi
Miho Kijima
Hajime Iwasaki
Akira Doshu-Kajiura
Osamu Kitajima
Takahiro Suzuki
Publication date
21-03-2021
Publisher
Springer Netherlands
Keyword
Rocuronium
Published in
Journal of Clinical Monitoring and Computing / Issue 2/2022
Print ISSN: 1387-1307
Electronic ISSN: 1573-2614
DOI
https://doi.org/10.1007/s10877-021-00692-2

Other articles of this Issue 2/2022

Journal of Clinical Monitoring and Computing 2/2022 Go to the issue